Granting additional market exclusivity to the drug Ansaid
Subtitle: hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1992
Place of publication: Washington
Language: eng
Number of pages: 66
Subjects: Upjohn Company.; Flurbiprofen.; Pharmaceutical policy -- United States.; Patent extensions -- United States.
Notes: Includes bibliographical references.
Item 1019-A, 1019-B (MF)
Distributed to some depository libraries in microfiche.
Shipping list no.: 92-0324-P.
"Serial no. 102-99."